Profenamine
From Wikipedia, the free encyclopedia
 |
|
|
Profenamine
|
|
| Systematic (IUPAC) name | |
| N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | N04 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H24N2S |
| Mol. mass | 312.473 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 93% |
| Metabolism | ? |
| Half life | 1 to 2 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Profenamine hydrochloride (INN, also known as ethopropazine) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism and the extrapyramidal effects of anticholinergic drugs.
It is sold under the trade names Parsidol in the United States and Parsidan in Canada.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
